Elexacaftor–Tezacaftor–Ivacaftor improves exercise capacity in adolescents with cystic fibrosis

OBJECTIVE: Elexacaftor/Tezacaftor/Ivacaftor is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator with the potential to improve exercise capacity. This case series of three adolescents with CF aimed to investigate whether 6 weeks treatment with Elexacaftor/Tezacaftor/Ivacaftor co...

Descripción completa

Detalles Bibliográficos
Autores principales: Causer, Adam J., Shute, Janis K., Cummings, Michael H., Shepherd, Anthony I., Wallbanks, Samuel R., Pulsford, Richard M., Bright, Victoria, Connett, Gary, Saynor, Zoe L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795914/
https://www.ncbi.nlm.nih.gov/pubmed/35851858
http://dx.doi.org/10.1002/ppul.26078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795914/
https://www.ncbi.nlm.nih.gov/pubmed/35851858
http://dx.doi.org/10.1002/ppul.26078

Ejemplares similares